Diabetes Technology

Latest News

Medtronic Recalls Certain MiniMed Insulin Pumps After Injuries Reported

By

Brian Park, PharmD

Medtronic is recalling certain MiniMed 600 Series insulin pumps due to a missing or broken retainer ring that can potentially lead to the under or over delivery of insulin.

Benefits of Insulin Plus Pramlintide in Artificial Pancreas Systems

By

Amit Akirov, MD

A novel dual-hormone artificial pancreas system that delivers both rapid insulin and pramlintide was found to improve glucose control.

CGM Improves Metabolic Control, Reduces DKA and Severe Hypoglycemia in Pediatric T1D

By

Morgan E. Meissner

Real-world use of continuous glucose monitoring systems improves glycemic control and reduces the frequency of rare and dangerous events in pediatric type 1 diabetes.

Mobile Closed-Loop Insulin System Lowers Hypoglycemia Risk in Type 1 Diabetes

By

Morgan E. Meissner

Automated insulin delivery by a mobile closed-loop control system represents a feasible option for glycemic control in type 1 diabetes, with some improvements still needed in device connectivity.

Telemedicine Care May Improve Management of Patients With Type 1 Diabetes

By

Amit Akirov, MD

Researchers explored the effects of a telemedicine visit on care in patients with T1D.

Intermittently Scanned CGM May Reduce Hypoglycemia in T1D

Intermittently scanned continuous glucose monitoring results in higher treatment satisfaction among adults with type 1 diabetes.

ADA 2020 Standards of Care Incorporate CVD Risk Stratification, New Medications

By

Rachael Beairsto

The American Diabetes Association (ADA) has published an update to their Standards of Medical Care in Diabetes for 2020.

Closed-Loop System Better Controls Blood Glucose Than Sensor-Augmented Insulin Pump

By

Amit Akirov, MD

A closed-loop insulin delivery system, also referred to as an artificial pancreas, was found to be more effective than sensor-augmented insulin pump therapy in patients with type 1 diabetes.

Fast-Acting Insulin Approved for Use in Insulin Infusion Pumps

By

Brian Park, PharmD

The FDA has expanded the indication for Fiasp (insulin aspart injection; Novo Nordisk) 100 Units/mL to include use in insulin infusion pumps to improve glycemic control in adults with type 1 or type 2 diabetes.

Comparison of Faster vs Standard Insulin Aspart in Fully Closed-Loop Insulin Therapy

By

Amit Akirov, MD

There were no clear benefits of using faster insulin aspart in closed-loop insulin therapy and the closed-loop algorithm was better adjusted to the use of standard insulin aspart.

FDA: Insulin Pumps Could Be Hacking Targets

Medical devices that can connect to the internet might be at risk for hacking, the U.S. Food and Drug Administration warned Tuesday.